The Triple Bottom Line (TBL) is Novo Nordisk’s way of doing business. We believe that a healthy economy, environment, and society are fundamental to long term business success. Therefore, we operate by taking social, financial, and environmental considerations into account when we make decisions. This ensures we manage our business sustainably and pursue solutions that are in the shared interests of the business and patients, and are in line with societal expectations.
To demonstrate our commitment to TBL, Novo Nordisk is one of only four companies in the world who have incorporated our philosophy into our company bylaws. As a result, the three pillars of TBL – Social Impact, Environmental Responsibility, and Financial Performance inform everything we do and guide every decision we make.
Our commitment to create value through innovation is our greatest contribution to society. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of protein-based products and delivery systems for type 1 and type 2 diabetes care, as well as in other therapeutic areas where we can make a difference.
Social responsibility is about caring for people. This applies to the people who depend on our products, as well as to our employees. We work to continuously integrate social, health, and safety considerations into our daily business.
The Diabetes Advocacy Alliance for example, which Novo Nordisk co-founded, is a coalition of 20 members representing patient advocacy organizations, professional societies, trade associations, other nonprofit organizations, and corporations committed to changing the way diabetes is viewed and treated in America. The member organizations work together to:
Environmental soundness addresses our impact on the external environment – and we've taken a concerted approach to ensure that our efforts to be green pay off.
Take for instance, our headquarters in the U.S. For Novo Nordisk, being responsible stewards of our environment is driven by the company’s commitment to help people live healthy lives. Our commitment to quality and our focus on maintaining high ethical standards goes hand in hand with living up to our responsibilities to shareholders, patients, society, and our own employees.
Utilizing recycled and locally-sourced materials, the new U.S. headquarters is consistent with Novo Nordisk's TBL business model. The LEED Silver certified campus is fully powered by renewable energy from wind, solar, and hydro sources – a feature that is expected to lead to a 30 percent reduction in energy costs.
The redeveloped building was designed to promote innovation, teamwork, and employee wellness. Features include a state-of-the-art cafeteria, a one-mile scenic walking path, and special quiet focus areas where employees can work effectively. The redesigned headquarters showcases Novo Nordisk's dedication to its unique internal culture and commitment to employees' personal growth – values that have earned the company recognition as a top employer.
Economic viability is about managing the business in a way that secures growth and value creation, and delivers competitive performance in these areas.
For example, we continuously invest in our employees. In fact, Novo Nordisk Inc. has been ranked in Fortune Magazine's Best Places to Work listing every year since 2009. Most recently, Novo Nordisk was presented with the New Good Neighbor Award by the New Jersey Business & Industry Association. This award was based on a variety of factors, including economic benefit/job creation, architectural merit, and community involvement. Our award-winning workplace and innovative achievements are consistently recognized for making a real difference in the lives of our patients and creating an unmatched setting for career advancement for our employees.
And Novo Nordisk is also committed to investing in Research and Development. In 2013, 14% of sales went towards funding R&D projects across the organization.